The Corporate Transformation of Medicine and Its Impact on Costs and Access to Care

References

1. ↵
   Relman AS. The new medical-industrial complex. N Engl J Med 1980; 303: 963–70.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   Munoz R. How health care insurers avoid treating mental illness. San Diego Union Tribune 2002 May 22.
3. ↵
   Stein L. Pulling the plug. Metro. Silicon Valley’s Weekly Newspaper 2002 Sep 20. Available at: URL: http://www.metroactive.com/papers/metro/09.19.02/hospital-0238.html.
4. ↵
   Committee on the Consequences of Uninsurance, Institute of Medicine. Shared destiny: community effects of uninsurance. Washington, DC: The National Academy Press, 2003: 51.
5. Hoerger TJ. “Profit” variability in for-profit and not-for-profit hospitals. J Health Econ 1991; 10: 259–89.

   OpenUrlCrossRefPubMedWeb of Science
6. Needleman J. For-profit conversions. Nonprofit to for-profit conversions by hospitals, health insurers, and health plans. Public Health Rep 1999; 114: 108–19.

   OpenUrlCrossRefPubMedWeb of Science
7. Zwanziger J, Melnick GA, Bamezai A. Can cost shifting continue in a price competitive environment? Health Econ 2000; 9: 211–26.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   Coye MJ. The sale of Good Samaritan: a view from the trenches. Health Aff (Millwood) 1997; 16: 102–7.

   OpenUrlPubMed
9. Martinez B. After an era of dominant HMOs, hospitals are turning the tables. Wall Street Journal 2002 Apr 12. Available at: URL: http://www.legacyalliance.net/Articles/News/HospitalsTurningTables.htm.
10. White RD. Tenet continuing resurgence. The Los Angeles Times. 2002 Jan 5.
11. ↵
    Silverman EM, Skinner JS, Fisher ES. The association between for-profit hospital ownership and increased Medicare spending. N Engl J Med 1999; 341: 420–6.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    Himmelstein DU, Woolhandler S, Hellander I. Bleeding the patient: the consequences of corporate healthcare. Monroe, ME: Common Courage Press, 2001: 127–8.
13. ↵
    Kuttner R. Columbia/HCA and the resurgence of the for-profit hospital business. N Engl J Med 1999; 335: 446–51.

    OpenUrl
14. ↵
    Woolhandler S, Himmelstein DU. Costs of care and administration at for-profit and other hospitals in the United States. N Engl J Med 1997; 336: 769–74.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    Hartz AJ, Krakauer H, Kuhn EM, et al. Hospital characteristics and mortality rates. N Engl J Med 1989; 321: 1720–5.

    OpenUrlCrossRefPubMedWeb of Science
16. ↵
    Chen J, Radford MJ, Wang Y, Marciniak TA, Krumholz HM. Do “America’s Best Hospitals” perform better for acute myocardial infarction? N Engl J Med 1999; 340: 286–92.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    Yuan Z, Cooper GS, Einstadter D, Cebul RD, Rimm AA. The association between hospital type and mortality and length of stay: a study of 16.9 million hospitalized Medicare beneficiaries. Med Care 2000; 38: 231–45.

    OpenUrlCrossRefPubMedWeb of Science
18. Kovner C, Gergen PJ. Nurse staffing levels and adverse events following surgery in U.S. hospitals. Image J Nurs Sch 1998; 30: 315–21.

    OpenUrlPubMed
19. ↵
    1998 Environmental assessment: setting foundations for the new millennium, survey. Irving, TX: VHA, Inc.; 1998.
20. ↵
    Kirchner M. Will you have to join a hospital chain to survive? Med Econ 1985; 62: 164–76.

    OpenUrlPubMed
21. ↵
    Mann JM, Melnick GA, Bamezai A, Zwanziger J. A profile of uncompensated hospital care, 1983–1995. Health Aff (Millwood) 1997; 16: 223–32.

    OpenUrlAbstract/FREE Full Text
22. ↵
    Needleman J, Lamphere J, Chollet D. Uncompensated care and hospital conversions in Florida. Health Aff (Millwood) 1999; 18: 125–33.

    OpenUrlFREE Full Text
23. ↵
    Desai KR, Lukas CV, Young GJ. Public hospitals: privatization and uncompensated care. Health Aff (Millwood) 2000; 19: 167–72.

    OpenUrlFREE Full Text
24. Deleted in proof.
25. ↵
    Data update. PNHP Newsletter. 2002 Jan:7.
26. ↵
    Abelson R. Nurses’ Association says in study that big hospital chain overcharges patients for drugs. The New York Times 2002 Nov 24; Sect. 1:26.
27. ↵
    Martinez B. HCA accusers may challenge U.S. settlement. The Wall Street Journal 2002 Dec 19; Sect. A:5.
28. ↵
    Data update. PNHP Newsletter. Spring 2003: 10.
29. ↵
    Kuttner R. Must good HMOs go bad? First of two parts: the commercialism of prepaid group health care. N Engl J Med 1998; 338: 1558–63.

    OpenUrlCrossRefPubMedWeb of Science
30. ↵
    Comparing Medicare HMOs. Do they keep their members? Washington, DC: Families USA, 1997.
31. ↵
    When things go wrong. Consumer Reports 1996; 62(8): 39–42.

    OpenUrl
32. ↵
    Himmelstein DU, Woolhandler S, Hellander I, Wolfe SM. Quality of care in investor-owned vs not-for-profit HMOs. JAMA 1999; 282: 159–63.

    OpenUrlCrossRefPubMedWeb of Science
33. ↵
    The HMO honor roll. U.S. News & World Report 1997 Oct 23:62.
34. ↵
    Kuttner R. The American health care system: Wall Street and health care. N Engl J Med 1999; 340: 664–8.

    OpenUrlCrossRefPubMedWeb of Science
35. ↵
    Duff C. Americans tell government to stay out—except in case of health care. The Wall Street Journal 1998 Jun 25; Sect. A:9,14.
36. Pollitz K, Crowley J, Lucia K, Bangit E. Assessing state external review programs and the effects of pending Federal patients’ rights legislation. Menlo Park, CA: Henry J. Kaiser Family Foundation, 2002.
37. Rush Prudential HMO Inc v Moran (00–1021), 230 F3d 959, affirmed. Available at: URL: http://www.supremecourtus.gov/opinions/01pdf/00-1021.pdf
38. Rice B. When an HMO denial is practicing medicine. Med Econ 2002; 79:100, 103, 107.
39. ↵
    McCormick D, Himmelstein DU, Woolhandler S, Wolfe SM, Bor DH. Relationship between low quality-of-care scores and HMOs subsequent public disclosure of quality-of-care scores. JAMA 2002; 288: 1484–90.

    OpenUrlCrossRefPubMedWeb of Science
40. ↵
    Court J, Smith F. Making a killing: HMOs and the threat to your health. Monroe, ME: Common Courage Press, 1999.
41. ↵
    Peeno L. HMOs seek whitewash instead of facing misdeeds. The Wall Street Journal 2002 Jul 26; Sect. A:11.
42. ↵
    Lee D. A bright spot in health insurance. The Los Angeles Times 2002 Apr 25; Sect. C:1.
43. ↵
    Waldholz M. Prescriptions. Medicare seniors face confusion as HMOs bail out of program. The Wall Street Journal 2002 Oct 3; Sect. D:4.
44. ↵
    Barry P. More HMOs leave Medicare. AARP Bulletin 2002 Nov;43:1.
45. ↵
    Lowes R. We nailed an HMO for $6 million. Med Econ 2002; 79(24): 60–2, 65–7.
46. ↵
    Lee D. Rising costs put pressure on Kaiser. The Los Angeles Times 2002 Sep 29.
47. ↵
    Competition in the markets. On Managed Care 2001 Apr;6:1.
48. ↵
    Song KM. Hospitals sue Premera to halt for-profit switch. Seattle Times 2003 Jan 23; Sect. A:1.
49. ↵
    Kuttner R. Everything for sale: the virtues and limits of markets. Chicago: University of Chicago Press, 1999.
50. ↵
    News release. FTCR calls for health care rate regulation. Santa Monica, CA: The Foundation for Taxpayer and Consumer Rights, 2002 Oct 4.
51. ↵
    Benko LB. Managed care. Shakeup in California. Modern Healthcare. 2002 May 13;32.
52. ↵
    Terhune C. Side effect. Insurer’s tactic: if you get sick, the premium rises. The Wall Street Journal 2002 Apr 9; Sect. A:1.
53. ↵
    Morrison AB, Wolfe SM. Outrage of the month. None of your business. Public Citizen’s Health Research Group Health Letter 2001; 17(2): 11.
54. ↵
    Terhune C. Insurers avoid state regulations by selling via groups elsewhere. The Wall Street Journal 2002 Apr 9;Sect. A:20.
55. ↵
    Terhune C. Non-profit groups that tout insurance have hidden links. The Wall Street Journal 2002 Nov 21;Sect. A.
56. ↵
    Tep R. Click here for coverage. Forbes.com. 2002 Nov 21. Available at: URL: http://www.forbes.com/best/2002/1202/005.html
57. ↵
    Martinez B. Cigna is stung in ploy to settle rival lawsuits. The Wall Street Journal 2002 Dec 20;Sect. B:1.
58. ↵
    McGinley L. General American to pay $76 million in Medicare case. The Wall Street Journal 2002 Jun 26;Sect. A:2.
59. ↵
    Managed Healthcare Market Report. March 2001:31.
60. ↵
    Public Citizen Report. April 18, 2002. Pharmaceutical industry ranks as most profitable industry—again. Public Citizen Report. 2002 Apr 18. Available at: URL: http://www.citizen.org/pressroom/release.cfm?ID=1088.
61. ↵
    Mintz M. Still hard to swallow. The Washington Post 2001 Feb; Health.
62. ↵
    Public Citizen Report. 2001 Jul.
63. ↵
    Relman AS, Angell M. America’s other drug problem: how the drug industry distorts medicine and politics. The New Republic 2002 Dec 16; 27–41.
64. ↵
    Baker D. Patent medicine. The American Prospect 2001 Jan 29: 34–5.
65. ↵
    Editorial. Gaming the patent drug system. The Los Angeles Times 2002 June:10.
66. ↵
    Ivins M. Drug companies antics can really make you sick. Public Citizen’s Health Research Group Health Letter 2001; 17(7): 4.
67. ↵
    GPHA rips PhRMA ad. O’Dwyer’s PR Services Report 2002 Nov:15.
68. ↵
    Baglole J. Glaxo tries new tack on cheap Canadian drugs. The Wall Street Journal. 2003 Jan 22;Sect. D:2.
69. ↵
    Angell M, Relman AE. Prescription for profit. The Washington Post 2001 Jun 20;Sect. A:27
70. ↵
    CBS. 60 Minutes. December 1999: r19.
71. ↵
    Deyo RA, Psaty BM, Simon G, Wagner EH, Omenn GS. The messenger under attack—intimidation of researchers by special-interest groups. N Engl J Med 1997; 336: 1176–80.

    OpenUrlCrossRefPubMedWeb of Science
72. ↵
    Moynihan R. The making of a disease: female sexual dysfunction. BMJ 2003; 326: 45–7.

    OpenUrlFREE Full Text
73. ↵
    Chartrand S. Patents: the Viagra counterpart for women is on its way and it addresses a clinical condition new to the popular lexicon. The New York Times 2003 Jan 27;Sect. C:7.
74. ↵
    Wolfe SM. Direct-to-consumer (DTC) ads: illegal, unethical or both. Public Citizen’s Health Research Group Health Letter 2001; 17(9): 3.
75. ↵
    Wolfe SM. Update on the illegal promotion of gabapentin (Neurontin). Public Citizen’s Health Research Group Health Letter 2002; 18(8): 3–5.
76. ↵
    Wolfe SM. Unsafe drugs: congressional silence is deadly (part 2). Public Citizen’s Health Research Group Health Letter 2002; 18(9): 1–4.
77. ↵
    DHHS. Inspector General report and New York Times. Associated Press Report. September 20; 2001.
78. ↵
    Press release. Families USA. July 2002:17.
79. ↵
    Kihlstrom LC. Characteristics and growth of managed behavioral health care firms. Health Aff (Millwood) 1997; 16: 127–30.

    OpenUrlFREE Full Text
80. ↵
    Wrich J. Brief summary of audit findings of managed behavioral health services. Chicago, IL: J. Wrich & Associates, Inc., 1998.
81. ↵
    Garg PP, Frick KD, Diener-West M, Powe NR. Effect of the ownership of dialysis facilities on patients’ survival and referral for transplantation. N Engl J Med 1999; 341: 1653–60.

    OpenUrlCrossRefPubMedWeb of Science
82. ↵
    Devereaux PJ, Schunemann HJ, Ravindran N, et al. Comparison of mortality between private for-profit and private not-for-profit hemodialysis centers: a systematic review and meta-analysis. JAMA 2002; 288: 2449–57.

    OpenUrlCrossRefPubMedWeb of Science
83. ↵
    Press release. Settlement with Fresenius Medical Care. Washington, DC: Office of Inspector General, US Department of Health and Human Services; 2000 Jan 19.
84. ↵
    Pear R. Government is called lenient toward errant nursing homes. The New York Times. 1998 Jul 27.
85. ↵
    Wolfe SM. Neglected to death: the scandalous condition of American nursing homes. Public Citizen’s Research Group Health Letter 2003; 19: 1–4.
86. ↵
    Mod Healthc 2000 Feb 7; 30(6).
87. Sullivan K. Strangled competition: a critique of Minnesota’s experiment with managed competition. St. Paul, MN: Minnesota COACT and COACT Education Foundation, 1995.
88. ↵
    Findley S. Research brief. National Institute for Health Care Management Research and Educational Foundation. Med Benefits 2000; 17: 5–6.
89. ↵
    Woolhandler S, Himmelstein DU. When money is the mission—the high costs of investor-owned care. N Engl J Med 1999; 341: 444–6.

    OpenUrlCrossRefPubMedWeb of Science
90. ↵
    Appleby J. More high-income Americans go without health insurance. USA Today 2002 Nov 22; Sect. B:1.
91. ↵
    Health Insurance Coverage in America: 2000 data update. Menlo Park, CA: Kaiser Commission on Medicaid and the Uninsured, 2002:9. Available at: URL: http://www.kff.org/content/2002/4007/4007.pdf
92. ↵
    Data update. PNHP Newsletter. Jan 2002: 6.
93. ↵
    Woolhandler S, Himmelstein DU. Paying for national health insurance—and not getting it. Health Aff (Millwood) 2002; 21: 88–98.

    OpenUrlAbstract/FREE Full Text
94. ↵
    Findley S. Bridge temporary insurance gaps. USA Today 2002 Sep 26;Sect. A:11.
95. ↵
    Institute of Medicine Report. October 2001: 11.
96. ↵
    Swartz K. Who owns the problem of the uninsured? Inquiry 1996; 33: 103–5.

    OpenUrlPubMed
97. ↵
    Committee on the Consequences of Uninsurance. Health insurance is a family matter. Washington, DC: The National Academy Press, 2002: 1–10.
98. Hadley J. Sicker and poorer: the consequences of being uninsured. Menlo Park, CA: Kaiser Commission on Medicaid and the uninsured. Kaiser Family Foundation, 2002.
99. Billings J, Minanoviteh T, Blank A. Barriers to care for patients with preventable hospital admissions. New York: United Hospital Fund, 1997.
100. Baker DW, Sudano JJ, Albert JM, Borawski EA, Dor A. Lack of health insurance and decline in overall health in late middle age. N Engl J Med 2001; 345: 1106–12.

     OpenUrlCrossRefPubMedWeb of Science
101. ↵
     Cunningham PJ. Prescription drug access: not just a Medicare problem. Issue brief no. 51. Washington, DC: Center for Studying Health System Change, 2002. Available at: URL: http://www.hschange.com/CONTENT/429/
102. ↵
     Wagner L. Citing national losses of $2.2 billion, physicians closing doors to seniors. Physician Financial News 2002 May 15; 20:1, 24.
103. ↵
     Institute for the Future. Health and Health Care 2010: the forecast, the challenges. San Francisco: Jossey-Bass, 2000; 123–37.
104. ↵
     Health spending to double. Practice Trends. Policy & Practice. Fam Pract News 2003; 33: 53.

     OpenUrl
105. ↵
     Renzulli D. Capitol offenders: how private interests govern our states. Washington, DC: Public Integrity Books, 2002: 149–66.